OBESITY
Faster Results with Rapid Execution
Accelerate your obesity trial timelines with solutions designed for rapid execution by leveraging our team of seasoned experts and advanced patient recruitment solutions.
Accelerate your obesity trial timelines with solutions designed for rapid execution by leveraging our team of seasoned experts and advanced patient recruitment solutions.
The global burden of obesity is rising, with 1 billion people worldwide expected to have obesity by 2030.
We are redefining the obesity clinical trial experience with innovative strategies that accelerate patient recruitment, enhance site operations, and ensure robust, reliable data collection—all while keeping patients at the center of the journey.
The IQVIA Institute offers stakeholder data, evidence and insights about important topics related to obesity, such as research methodologies, health economic implications and more.
Stay ahead of the curve by taking advantage of our industry insights on the global health challenges around obesity.
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Helping Sites and Investigators grow through innovation and collaboration
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.